Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab

Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab: We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.